These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36943203)

  • 1. Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.
    DE Bastiani R; Lopetuso LR; DE Bastiani M; Bacchin P; Benedetto E; Boscariolo L; Caneve R; Chesani F; Chiumeo F; Civic Z; Dainese A; DE Polo M; Disclafani G; Grattagliano I; Mana O; Mancuso M; Mastronuzzi T; Pati A; Pirrotta E; Salandini M; Sanna G; Scoglio R; Severino P; Tosetti C; Turnava L; Zamparella M; Elisei W; Gasbarrini A; Tursi A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):523-528. PubMed ID: 36943203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of continuous proton pump inhibitor therapy on small intestinal bacterial overgrowth in elderly].
    Zhang R; Li Y; Ma JX; Tang S; Li CM; Wan J
    Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):706-710. PubMed ID: 32838502
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.
    Chedid V; Dhalla S; Clarke JO; Roland BC; Dunbar KB; Koh J; Justino E; Tomakin E; Mullin GE
    Glob Adv Health Med; 2014 May; 3(3):16-24. PubMed ID: 24891990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.
    Barkin JA; Keihanian T; Barkin JS; Antequera CM; Moshiree B
    Rev Gastroenterol Peru; 2019; 39(2):111-115. PubMed ID: 31333225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors
    Revaiah PC; Kochhar R; Rana SV; Berry N; Ashat M; Dhaka N; Rami Reddy Y; Sinha SK
    JGH Open; 2018 Apr; 2(2):47-53. PubMed ID: 30483563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.
    Law D; Pimentel M
    Dig Dis Sci; 2010 Aug; 55(8):2302-8. PubMed ID: 19834807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit.
    Suri J; Kataria R; Malik Z; Parkman HP; Schey R
    Medicine (Baltimore); 2018 May; 97(21):e10554. PubMed ID: 29794732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of food patterns with different forms of small intestinal bacterial overgroth syndrome and treatment efficacy].
    Pilipenko VI; Isakov VA; Morozov SV; Vlasova AV; Naydenova MA
    Ter Arkh; 2019 Oct; 91(10):82-90. PubMed ID: 32598636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.
    Furnari M; De Alessandri A; Cresta F; Haupt M; Bassi M; Calvi A; Haupt R; Bodini G; Ahmed I; Bagnasco F; Giannini EG; Casciaro R
    J Gastroenterol; 2019 Mar; 54(3):261-270. PubMed ID: 30232597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis.
    Kim DB; Paik CN; Sung HJ; Chung WC; Lee KM; Yang JM; Choi MG
    Pancreatology; 2015; 15(5):514-518. PubMed ID: 26278025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
    Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).
    Ní Chonchubhair HM; Bashir Y; Dobson M; Ryan BM; Duggan SN; Conlon KC
    Pancreatology; 2018 Jun; 18(4):379-385. PubMed ID: 29502987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M; McCallum RW
    Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth.
    Gabbard SL; Lacy BE; Levine GM; Crowell MD
    Dig Dis Sci; 2014 Mar; 59(3):638-44. PubMed ID: 24323179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Small Intestinal Bacterial Overgrowth and Symptoms After 7 Days of Proton Pump Inhibitor Use: A Study on Healthy Volunteers.
    Durán-Rosas C; Priego-Parra BA; Morel-Cerda E; Mercado-Jauregui LA; Aquino-Ruiz CA; Triana-Romero A; Amieva-Balmori M; Velasco JAV; Remes-Troche JM
    Dig Dis Sci; 2024 Jan; 69(1):209-215. PubMed ID: 37910339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.